Hamden, CT, United States of America

Pedram Zendehrouh

This inventor holds 1 USPTO granted patent. Top assignees: Temple University, University of Utah Research Foundation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedram Zendehrouh. Retrieved from https://idiyas.com/inventor/pedram-zendehrouh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedram Zendehrouh: Innovator in Antithrombin Research

Introduction

Pedram Zendehrouh is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified antithrombin III compounds. His work focuses on addressing blood clotting disorders and related diseases.

Latest Patents

Zendehrouh holds a patent for "Human antithrombin IIIs and methods related thereto." This invention discloses modified antithrombin III compounds and methods that are useful in treating blood clotting disorders. The amino acid compounds developed in this patent have potential applications in various disease states associated with enzymes in the coagulation pathway.

Career Highlights

Throughout his career, Zendehrouh has worked with esteemed institutions such as the University of Utah Research Foundation and Temple University. His experience in these organizations has contributed to his expertise in the field of coagulation and enzyme research.

Collaborations

Zendehrouh has collaborated with notable colleagues, including Veronique Picard and Susan C. Bock. These partnerships have further enhanced his research and development efforts in the area of antithrombin III.

Conclusion

Pedram Zendehrouh is a distinguished inventor whose work in modified antithrombin III compounds has the potential to impact the treatment of blood clotting disorders significantly. His contributions to biochemistry and collaboration with leading researchers highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…